Skip to main content

Newsroom

Latest News

April 8, 2020

During recent appearances, President Donald Trump has energetically hyped hydroxychloroquine and chloroquine as potential miracle cures for COVID-19, even though they haven't been approved for this purpose by U.S. agencies and the only evidence that they may have a positive effect is purely anecdotal. His argument can basically be summarized like so: The drugs have proven safe in other contexts, and if they don't do anything to knock down the novel coronavirus, no harm/no foul.

April 8, 2020

Colorado Congresswoman Diana DeGette wants the FDA to look into the hoarding of drugs used to treat coronavirus. She said the prescriptions for hydroxychloroquine can take away the drugs from those who really need them.

Hydroxychloroquine has been touted by President Donald Trump as a treatment for COVID-19 patients. There is a dispute among medical professionals about the effectiveness of the drug for coronavirus.

Using it for coronavirus has also resulted in a huge demand and shortage.

April 6, 2020
DENVER, CO – U.S. Reps. Diana DeGette (D-CO), Jared Huffman (D-CA) and Jan Schakowsky (D-IL) sent a letter to Health and Human Services Secretary Alex Azar today urging him to immediately lift restrictions on human fetal tissue research, which are preventing scientists from advancing important studies to potentially prevent, treat and cure the novel coronavirus.
April 6, 2020

More than a dozen House Democrats on Monday called on the Trump administration to lift restrictions on research that uses human fetal tissue to allow for studies on potential treatment for COVID-19.

The lawmakers argued in a letter to Health and Human Services Secretary Alex Azar that such studies could lead to developing coronavirus treatments more quickly. Public health officials have estimated that a vaccine will not be available for at least another 12 to 18 months.

April 3, 2020
DENVER, CO – U.S. Rep. Diana DeGette (D-CO) sent a letter to Health and Human Services Secretary Alex Azar today on his agency’s failure to fully utilize all available sources of existing ventilators across the various federal stockpiles.
April 3, 2020
DENVER, CO – U.S. Rep. Diana DeGette (D-CO), chair of the House Energy and Commerce Committee’s Oversight and Investigations panel – which oversees the agencies responsible for responding to the spread of the coronavirus – blasted the Trump administration today for changes to the Strategic National Stockpile website.
April 1, 2020

U.S. Rep. Diana DeGette gave a glimpse into the next potential piece of federal coronavirus legislation on Tuesday night, saying that it might contain continuing financial aid to individuals, and vowed that a congressional investigation of the federal government's response would take place after the end of the COVID-19 pandemic.

"I will assure you that once we're past this — and even now, I'm talking to my staff about putting together a very robust investigation to make sure this never happens again," she said on a call with constituents.

March 27, 2020
WASHINGTON, D.C. – The U.S. House of Representatives today approved a critical economic relief package to help workers and small businesses impacted by the coronavirus pandemic.
March 27, 2020
Today, the House passed a critical economic relief package to bring immediate relief to the millions of American families now struggling to make ends meet. Most importantly, this legislation puts workers and their families first.
March 27, 2020

President Donald Trump signed the $2.2 trillion CARES Act – the federal government's coronavirus economic relief package – on Friday afternoon after the House passed the bill by a voice vote earlier in the day.

We gathered up reaction from all of Colorado's members of Congress on the passage of the package, which you can find below. (Rep. Doug Lamborn, R-Colo., had not yet issued a statement as of 5:45 p.m. MT)

Sen. Michael Bennet (D)